Evidence map›Paper›PMID 22036210›Full record

ArticleBioorganic & medicinal chemistry2011

Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells.

Ashkan Emadi, Anne Le, Cynthia J Harwood, Kenneth W Stagliano, Farin Kamangar, Ashley E Ross, Charles R Cooper, Chi V Dang, Judith E Karp, Milena Vuica-Ross

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ashkan EmadiJohns Hopkins University, School of Medicine, Department of Internal Medicine, Division of Hematology, 720 Rutland Avenue, Baltimore, MD 21205, USA. aemadi1@jhmi.edu
Anne Le
Cynthia J Harwood
Kenneth W Stagliano
Farin Kamangar
Ashley E Ross
Charles R Cooper
Chi V Dang
Judith E Karp
Milena Vuica-Ross
Johns Hopkins Medicine · USIllinois Institute of Technology · USJohns Hopkins University · USMorgan State University · USPurdue University West Lafayette · US

Funding

TRAINING PROGRAM IN HEMATOLOGYT32HL007525 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ROBERT A BRODSKY · 1985 to 2026
$6.2M
PALLADIUM CATALYZED COUPLING APPROACHES TO CONOCURVONER01AI043687 · NIAID · ILLINOIS INSTITUTE OF TECHNOLOGY · PI STAGLIANO, KENNETH · 1999 to 2002
$440k
NHLBI NIH HHS T32 HL007525NIAID NIH HHS AI43687NIAID NIH HHS R01 AI043687PHS HHS T-32
6 · The paper itself

Abstract

Cancer cells reprogram their metabolism due to genetic alteration to compensate for increased energy demand and enhanced anabolism, cell proliferation, and protection from oxidative damage. Here, we assessed the cytotoxicity of three dimeric naphthoquinones against the glycolytic MCF-7 versus the oxidative MDA-453 breast carcinoma cell lines. Dimeric naphthoquinones 1 and 2 impaired MDA-453, but not MCF-7, cell growth at IC(50)=15 μM. Significant increase in reactive oxygen species, decrease in oxygen consumption and ATP production were observed in MDA-453 cells but not in MCF-7 cell. These findings suggest that oxidative stress and mitochondrial dysfunction are mechanisms by which these agents exert their cytotoxic effects. Cyclic voltammetry and semi-empirical molecular orbital calculations further characterized the electrochemical behavior of these compounds. These results also suggest that dimeric naphthoquinones may be used to selectively target cancer cells that depend on oxidative phosphorylation for energy production and macromolecular synthesis.

Indexed as

Breast NeoplasmsCell Growth ProcessesCell Line, TumorFemaleHumansNaphthoquinonesOxidative StressReactive Oxygen SpeciesNaphthoquinonesReactive Oxygen Species

Identifiers

PMID22036210
PMCPMC3216315
OpenAlexW1975428419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.